Susan Duggan
Directeur des opérations chez TRANSCODE THERAPEUTICS, INC.
Postes actifs de Susan Duggan
Sociétés | Poste | Début | Fin |
---|---|---|---|
TRANSCODE THERAPEUTICS, INC. | Directeur des opérations | - | - |
Historique de carrière de Susan Duggan
Anciens postes connus de Susan Duggan
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEDTRONIC PLC | Corporate Officer/Principal | - | - |
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Corporate Officer/Principal | 01/03/2018 | - |
Formation de Susan Duggan
Colby-Sawyer College | Undergraduate Degree |
Rivier University | Masters Business Admin |
Northern Essex Community College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Irlande | 2 |
Opérationnelle
Undergraduate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MEDTRONIC PLC | Health Technology |
TRANSCODE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Samus Therapeutics, Inc.
Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Bourse
- Insiders
- Susan Duggan
- Expérience